| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.009 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |